Hydrochloric Acid

Hydrochloric Acid

SCHEMBL25335404

NC(=O)c1cc2n(n1)CCCNC2.[Cl-].[H+]

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 1/20 0.36
CHRNA4 P43681 1/20 0.36
GSK3B P49841 1/20 0.34
RIPK2 O43353 3/20 0.33
LCK P06239 3/20 0.33
KDR P35968 3/20 0.33
TGFBR1 P36897 3/20 0.33
PDCD1 Q15116 1/20 0.32
CD274 Q9NZQ7 1/20 0.32
CXCR4 P61073 1/20 0.30
PNMT P11086 1/20 0.30
OPRM1 P35372 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22887771 0.97 CHRNB2 (0.38) CHRNB2CHRNA4GSK3BRIPK2LCK
Hydrochloric Acid SCHEMBL25335409 0.96 CHRNB2 (0.37) CHRNB2CHRNA4GSK3BRIPK2LCK
SCHEMBL30793436 0.93 CHRNB2 (0.35) CHRNB2CHRNA4GSK3BRIPK2LCK
SCHEMBL1684264 0.88 PDCD1 (0.39) CHRNB2CHRNA4GSK3BPDCD1CD274
SCHEMBL22831695 0.84 PDCD1 (0.36) CHRNB2CHRNA4PDCD1CD274CXCR4
SCHEMBL23653232 0.82 CXCR4 (0.36) CHRNB2CHRNA4PDCD1CD274CXCR4
Hydrochloric Acid SCHEMBL27033568 0.82 PDCD1 (0.32) PDCD1CD274CXCR4
SCHEMBL24535306 0.80 HTR2A (0.42)
SCHEMBL24535290 0.79 PDCD1 (0.33) PDCD1CD274CXCR4
SCHEMBL24535881 0.79 BAZ2B (0.41) PDCD1CD274CXCR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4472980-A2 QUINAZOLINE PAN-KRAS INHIBITORS Mirati Therapeutics, Inc. (US) 2024-12-11 EP disclosed
WO-2023150284-A2 QUINAZOLINE PAN-KRAS INHIBITORS Mirati Therapeutics, Inc. (US) 2023-08-10 WO disclosed